Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

laboratorios syva, s.a.u. - benzylpenicillin, procain, monohydrat - injektionsvæske, suspension - 300 mg/ml

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

vetcare oy - benzylpenicillin, procain, monohydrat - intramammær suspension - 600 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

bimeda animal health limited - benzylpenicillin, procain - injektionsvæske, suspension - 300 mg/ml

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

agepha pharma s.r.o. - oxybuprocainhydrochlorid - øjendråber, opløsning - 4 mg/ml

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - oxybuprocainhydrochlorid - øjendråber, opløsning - 4 mg/ml

Danska - danski - SEGES Landbrug & Fødevarer

agros - prothioconazol - emulsionskoncentrat - 250 g/l prothioconazol

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - formoterolfumarat dihydrat - inhalationspulver, hård kapsel - 12 mikrogram

Europska Unija - danski - EMA (European Medicines Agency)

sanofi b.v. - laronidase - mucopolysaccharidose i - andre alimentary tract and metabolism produkter, - aldurazyme er angivet for en langsigtet enzymsubstitutionsbehandlingen i patienter med en bekræftet diagnose på mucopolysaccharidosis jeg (mps jeg; alfa-l-iduronidase mangel) til at behandle nonneurological manifestationer af sygdommen.

Europska Unija - danski - EMA (European Medicines Agency)

merz pharmaceuticals gmbh - memantinhydrochlorid - alzheimers sygdom - andre anti-demensmidler - behandling af patienter med moderat til svær alzheimers sygdom.

Europska Unija - danski - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).